Skip to main content
. 2018;19(11):3187–3192. doi: 10.31557/APJCP.2018.19.11.3187

Table 3.

Association between CD56, CD11b and Smac/DIABLO Expression and Response of Patients to Chemotherapy

Variables Complete remission N=38 Primary resistance N=13 Early relapse N=7 *p value
CD11b
 +ve 16 10 5 0.046*
 -ve 22 3 2
CD56
 +ve 15 9 5 0.035*
 -ve 23 4 2
Smac/DIABLO
 High 24 2 1 0.001*
 low 14 11 6
*

Statistically significant at p≤0.05; NS, Not statistically significant.